Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Mustang Bio shares are trading higher after the company announced the FDA accepted its IND application of MB-109 for the treatment of recurrent glioblastoma and high-grade astrocytoma.

Author: Benzinga Newsdesk | October 26, 2023 12:04pm

Posted In: MBIO